Bioalliance Pharma

Developer of medicines for cancer, HIV, and opportunistic infections

placeParis, Ile De France, France calendar_todayFounded 1997 language bioalliancepharma.com

Innovation

37 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 710 times.

YearFilings
201210
20134
20146
20152
20164
20172
20191
20201
20211

Investor mix

8 investors on record; lead investors include Auriga Partners.

Investor typeCountShare
Venture capital450%
Private equity113%
Other / undisclosed338%
Coming soon